Skip to content

High Intensity Interval Training in Geriatrics

High Intensity Interval Training for thE Rehabilitation of Geriatric Patients - a Feasibility Pilot studY.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02318459
Acronym
HIITERGY
Enrollment
100
Registered
2014-12-17
Start date
2014-05-31
Completion date
2016-02-29
Last updated
2016-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gait, Unsteady, Muscle Weakness

Brief summary

This is a pilot study for evaluating the feasibility of using High Intensity Interval Training in geriatric hospitalized patients compared to the standard current rehabilitation practice.

Detailed description

High Intensity Interval Training (HIIT) has shown a superior effectiveness and efficiency when compared to Moderate Intensity Continuous Training (MICT) in several types of patients and in healthy subjects. There are no data on HIIT in a general geriatric population. This study is a pilot study evaluating the feasibility of using HIIT in geriatric hospitalized patients compared to the standard current rehabilitation practice without HIIT. It is our desire to perform a larger randomized comparative trial between HIIT and MICT if the pilot study proves its feasibility.

Interventions

OTHERhigh intensity interval training-HIIT

HIIT 4 times a week, 30 minutes duration

OTHERTraditionnal group rehabilitation

Traditionnal group rehabilitation, 3 times a week, 1 hour duration

Sponsors

University Hospital, Geneva
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 65 years and older hospitalized for rehabilitation after an acute medical condition * Expected duration of the rehabilitation ≥ 2 weeks * Ability to follow instructions to perform a Timed up and Go Test * Ability to perform exercises * Willing to participate in 4 sessions of HIIT per week for 2 weeks

Exclusion criteria

* Any acute condition with tachycardia, hypotension or fever. * Abnormal cycle ergometer stress test with * significant ECG modification * decrease of more than 20 mmHg of the blood pressure with exercise * angina * ST depression at a workload \<6 METs * Inability to reach an intensity of 15/20 in the Borg's scale of perceived exertion * Any unresolved acute medical or surgical condition of the following kind: * acute heart failure * acute coronary syndrome \< 1 month * strole \< 1 month * active pericarditis / myocarditis / endocarditis * thromboembolic disease with \< 2 weeks of anticoagulation * acute infection requiring intravenous treatment * ongoing intravenous perfusion * surgery \< 2 months * recent bone fracture * Previous episode of primary cardiac arrest (ie, cardiac arrest that did not occur in the presence of an acute myocardial infarction or during a cardiac procedure). * Severe heart failure (NYHA III and IV) * Severe stenotic or regurgitant valvular disease * Uncontrolled hypertension at rest (SBP≥160mmHg, DBP≥100mmHg) * Uncontrolled dysrhythmia * Non-sustained ventricular tachycardia with exercise * Implanted defibrillator * Obstructive cardiomyopathy * Resting HR \> 100/min * Severe peripheral artery disease * Severe COPD (VEMS \< 50%) * Exercise-induced asthma * Oxygen dependency * Muscular-skeletal anomaly that may limit exercise participation * Delirium * Inability to follow instructions * Inability to consent

Design outcomes

Primary

MeasureTime frame
Proportion of patients who complete the rehabilitation program2 weeks

Secondary

MeasureTime frameDescription
Distance walked in the 6MWT2 weeks
Muscle strength assessed for the upper and lower extremities2 weeksupper extremity : handgrip strength using the Baseline Pneumatic Bulb Hand Dynamometer Pinch Gauge; Lower exremity : knee flexion & extension and ankle flexion & extension using Microfet2™portable Dynamometer.
Step variability changes as a measure of quality of ambulation2 weeksVariability measured with GaitRite step analysis system

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026